Crinetics shares PATHFNDR trial data showing oral Palsonify maintained hormone and symptom control in acromegaly patients over 84–96 weeks. read more

Amylyx reports strong Phase 2b trial data for avexitide, showing 64% fewer hypoglycemic events in patients with post-bariatric hypoglycemia. read more

Pudgy Penguins (CRYPTO: PENGU) has surged more than 90% in a week as bullish momentum builds around strong fundamentals, brand utility, and regulatory developments. read more

Salesforce’s Service Cloud unit is expected to generate $9.7B revenue in 2026, with 8.5% growth rate and potential for 12% in the long run. Analyst praises AI-powered Agentforce and projects $1.7B revenue and 9% CAGR in 5 years. Flexible pricing and cross-selling also contribute to Salesforce’s growth potential. Latest Ratings for CRM Date Firm Action…

Meta Platforms Inc. (NASDAQ: META) is ramping up its artificial intelligence infrastructure plans, with CEO Mark Zuckerberg confirming that the company will invest hundreds of billions of dollars into compute resources as it chases superintelligence. read more

Rocket Lab shares hit a new all-time high in early Monday trading. The stock is being fueled by a price target increase from Citigroup. read more

Goldman Sachs analyst initiates coverage of Nebius Group with a Buy rating, citing its strong position in the AI Neoclouds market. read more

U.S. equities traded sideways on Monday as investor sentiment wavered following President Donald Trump‘s weekend announcement of a sweeping 30% tariff on all imports from the European Union and Mexico, set to take effect August 1. read more